Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-150-0 | CAS number: 63449-39-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
There is adequate data to assess the mutagenic potential of LCCPs. LCCPs, like the SCCPs and the MCCPs, do not induce mutations in bacteria. There is some evidence of weak clastogenic potentialin vitroin mammalian cells,withchromosomal aberrations observed in CHO cells (with metabolic activation) and also sister chromatid exchanges (at 5-5000µg/mL with and without activation); however,no evidence of chromosomal aberrations was seen in a well-conductedin vivostudy in rat bone marrow cells, in which the rats received doses of up to 5000 mg/kg bwt/day for 5 days by gavage. There wasalso a negative mouse lymphoma assay conducted by the NTP on C23(average)liquid LCCP.Taking all of the data on LCCPs into account and considering what is known about shorter chain CPs, it is concluded that LCCPs, as a group, are without significantgenotoxicpotential. (From OECD SIAP October 2009)
In summary, LCCPs, like other CPs, do not induce mutations in bacteria. There is some evidence of weak clastogenic potentialin-vitroin mammalian cells, but this is not seenin-vivoin rat bone marrow cells. Taking all of the data on LCCPs into account and considering what is known about shorter chain CPs, it is concluded that LCCPs, as a group, are without significant mutagenic potential.
Short description of key information:
Valid studies of liquid grade LCCP products have been shown to be negative in the Ames test, using the Salmonella strains shown below, both with and without metabolic activation. On the other hand, the C23 (average) 43% Cl LCCP product was shown to cause chromosomal aberrations in Chinese hamster ovary (CHO) cells at a concentration of 5000 g/ml with metabolic activation. It also caused sister chromatid exchanges in CHO cells at concentrations ranging from 5.0 to 5000 ug/ml, both with and without metabolic activation.
In vivo, both a C22-26, 43%Cl and a C22-28, 70%Cl LCCP product showed no evidence of chromosome aberrations in rat bone marrow cells (Fischer 344) following the administration of either product by gavage at doses of 500, 1500 or 5000 mg/kg bwt/day for 5 days.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
